Vijaya Diagnostic Centre Limited — PPTs, 07-05-2026: Investor Presentation

**Business Performance:** Vijaya Diagnostic crushed Q4 & FY26 results! Q4 revenue soared 26.6% YoY to **₹219.4 Cr**, with PAT jumping 37.5% to **₹47.9 Cr**. Full-year FY26 revenue hit **₹814.2 Cr** (up 19.5% YoY) and PAT reached **₹173.0 Cr** (up 20.3% YoY). This marks FY26 as a landmark year, outperforming their 5-year CAGR revenue guidance, with strong 43.5% Q4 EBITDA margins. Pathology (63% revenue) and radiology drove broad-based growth, with Hyderabad leading geographically.

**Growth Strategy:** Expansion is key! New hubs in Khammam, Nandyal, and Pune broke even fast, boosting confidence in scaling. FY27 plans include 4-5 new hubs and 10-12 spokes, plus a fully automated lab in Hyderabad for faster turnaround times. They're also rolling out advanced genomic testing.

**Recent Developments:** Notable moves include the merger of Medinova Diagnostic Services and the acquisition of Pune's P.H. Diagnostics. Tech-wise, new CRM, ERP, and AI-driven radiology solutions are enhancing accuracy and productivity.

**Financials & Outlook:** FY26 Basic EPS grew 20.2% to **₹16.8**. Management is bullish, pointing to network doubling in 5 years and confident in continued growth through strategic expansion and tech adoption.